Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario.

CONCLUSION: These findings suggest that the EverProTM EES is a safe and effective treatment option with no MACE or stent thrombosis reported during the 1-year study period in patients with CAD. PMID: 33391614 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33391614?dopt=Abstract

Source: World Journal of Cardiology - December 26, 2020 Category: Cardiology Authors: Trimukhe R, Vani P, Patel A, Salgotra V Tags: World J Cardiol Source Type: research